FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3029620526> ?p ?o ?g. }

• W3029620526 endingPage "627" @default.
• W3029620526 startingPage "622" @default.
• W3029620526 abstract "ObjectiveTo observe the effect of Allicin on renal tissue fibrosis in chronic renal failure (CRF) and to study the protective mechanism of Allicin on CRF rats. MethodsThe CRF rat models were established by intragastric administration of adenine solution (250 mg/kg) for 21 days. After successful modeling, 80 model rats were randomly divided into the normal control group, the model group and the allicin low, medium and high dose groups using a random number table method (n=20). Allicin low-, medium-, and high-dose groups were intragastrically administered with 2.5, 5, and 10 mg/ml of allicin respectively. The model group and normal control group were given an equal volume of normal saline, and were administered at 2 ml/kg body weight of the rats, with once a day continuous administration for 28 d. Two hours after the last dose, the kidney mass was measured and the kidney index was calculated. The pathological changes of renal tissue was observed by HE staining; the serum BUN, SCr, uric acid, and 24-hour urinary protein levels were measured by a biochemical analyzer; the levels of CRP, IL-6 and TNF-α in serum and the levels of ollagen type Ⅳ(CⅣ), type Ⅲ procollagen (PCⅢ), laminin (LN), Fibronectin (FN) in plasma were by ELISA; the expression of collagen type Ⅰ (Col Ⅰ), plasminogen activator inhibitor-1 (PAI-1) and MMP-1 were observed by mmunohistochemical staining. ResultsCompared with model group, the bodyweight of rats in allicin medium, high dose groups were increased and kidney index decreased (P<0.05 or P<0.01), kidney histopathology scores decreased (P<0.01). Compared with model group, the level of BUN (14.51 ± 2.76 mmol/L, 11.48 ± 2.43 mmol/L vs. 24.07 ± 3.82 mmol/L), SCr (116.28 ± 27.35 μmol/L, 106.57 ± 24.18 μmol/L vs. 134.89 ± 35.02 μmol/L), Uric acid (83.34 ± 16.42 mmol/L, 77.86 ± 13.97 mmol/L vs. 114.76 ± 16.53 mmol/L), 24 h urinary protein (152.79 ± 48.43 mg, 137.03 ± 42.61 mg vs. 177.94 ± 96.47 mg), CRP (8.79 ± 1.84 mg/L, 7.51 ± 1.69 mg/L vs. 11.64 ± 1.95 mg/L), TNF-α (184.37 ± 24.15 ng/L, 126.82 ± 12.96 ng/L vs. 255.87 ± 31.93 ng/L) in the allicin medium and high dose groups were significantly decreased (P<0.05 or P<0.01); the levels of C-Ⅳ (40.26 ± 7.12 ng/ml, 23.79 ± 4.25 ng/ml vs. 67.53 ± 8.39 ng/ml), PC-Ⅲ (32.03 ± 5.89 ng/ml, 24.31 ± 5.84 ng/ml vs. 54.20 ± 7.08 ng/ml), LN (99.05 ± 38.17 ng/ml, 83.42 ± 28.83 ng/ml vs. 117.83 ± 35.76 ng/ml) in plasma in the allicin medium and high dose groups were significantly decreased and the level of FN (98.58 ± 21.43 mg/L, 125.96 ± 25.12 mg/L vs. 66.72 ± 13.09 mg/L) in plasma in the allicin medium and high dose groups were significantly increased (P<0.05 or P<0.01); the expression of Col Ⅰ (0.17 ± 0.03, 0.09 ± 0.03 vs. 0.27 ± 0.05), PAI-1 (0.20 ± 0.05, 0.16 ± 0.04 vs. 0.31 ± 0.08) were down-regulated and the expression of MMP-1 (0.10 ± 0.03, 0.22 ± 0.05 vs. 0.04 ± 0.02) were up-regulated (P<0.05 or P<0.01). ConclusionAllicin has protective effects on CRF rats by inhibiting the renal tissue fibrosis and alleviating inflammation.Key words: Allicin; Kidney failure, chronic; Inflammation; Rats" @default.
• W3029620526 created "2020-06-05" @default.
• W3029620526 creator A5059304831 @default.
• W3029620526 creator A5085166114 @default.
• W3029620526 date "2018-07-30" @default.
• W3029620526 modified "2023-09-23" @default.
• W3029620526 title "Effect of allicin on chronic renal failure rats by inhibiting renal fibrosis" @default.
• W3029620526 doi "https://doi.org/10.3760/cma.j.issn.1673-4246.2018.07.011" @default.
• W3029620526 hasPublicationYear "2018" @default.
• W3029620526 type Work @default.
• W3029620526 sameAs 3029620526 @default.
• W3029620526 citedByCount "0" @default.
• W3029620526 crossrefType "journal-article" @default.
• W3029620526 hasAuthorship W3029620526A5059304831 @default.
• W3029620526 hasAuthorship W3029620526A5085166114 @default.
• W3029620526 hasConcept C126322002 @default.
• W3029620526 hasConcept C134018914 @default.
• W3029620526 hasConcept C185592680 @default.
• W3029620526 hasConcept C2777397205 @default.
• W3029620526 hasConcept C2779679481 @default.
• W3029620526 hasConcept C2779881121 @default.
• W3029620526 hasConcept C2780091579 @default.
• W3029620526 hasConcept C2780559512 @default.
• W3029620526 hasConcept C2781005338 @default.
• W3029620526 hasConcept C55493867 @default.
• W3029620526 hasConcept C71924100 @default.
• W3029620526 hasConceptScore W3029620526C126322002 @default.
• W3029620526 hasConceptScore W3029620526C134018914 @default.
• W3029620526 hasConceptScore W3029620526C185592680 @default.
• W3029620526 hasConceptScore W3029620526C2777397205 @default.
• W3029620526 hasConceptScore W3029620526C2779679481 @default.
• W3029620526 hasConceptScore W3029620526C2779881121 @default.
• W3029620526 hasConceptScore W3029620526C2780091579 @default.
• W3029620526 hasConceptScore W3029620526C2780559512 @default.
• W3029620526 hasConceptScore W3029620526C2781005338 @default.
• W3029620526 hasConceptScore W3029620526C55493867 @default.
• W3029620526 hasConceptScore W3029620526C71924100 @default.
• W3029620526 hasIssue "7" @default.
• W3029620526 hasLocation W30296205261 @default.
• W3029620526 hasOpenAccess W3029620526 @default.
• W3029620526 hasPrimaryLocation W30296205261 @default.
• W3029620526 hasRelatedWork W2184994912 @default.
• W3029620526 hasRelatedWork W2367772813 @default.
• W3029620526 hasRelatedWork W2386769351 @default.
• W3029620526 hasRelatedWork W2399340601 @default.
• W3029620526 hasRelatedWork W2414484503 @default.
• W3029620526 hasRelatedWork W2800559613 @default.
• W3029620526 hasRelatedWork W3025348430 @default.
• W3029620526 hasRelatedWork W3028773205 @default.
• W3029620526 hasRelatedWork W3029269885 @default.
• W3029620526 hasRelatedWork W3029943089 @default.
• W3029620526 hasRelatedWork W3030009012 @default.
• W3029620526 hasRelatedWork W3030357925 @default.
• W3029620526 hasRelatedWork W3030585503 @default.
• W3029620526 hasRelatedWork W3030759190 @default.
• W3029620526 hasRelatedWork W3030829310 @default.
• W3029620526 hasRelatedWork W3031040445 @default.
• W3029620526 hasRelatedWork W3031184027 @default.
• W3029620526 hasRelatedWork W3032172324 @default.
• W3029620526 hasRelatedWork W3032494009 @default.
• W3029620526 hasRelatedWork W3096407140 @default.
• W3029620526 hasVolume "40" @default.
• W3029620526 isParatext "false" @default.
• W3029620526 isRetracted "false" @default.
• W3029620526 magId "3029620526" @default.
• W3029620526 workType "article" @default.